Bespalov A Y, Beardsley P M, Balster R L
Department of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0613, USA.
Pharmacol Biochem Behav. 1998 Jun;60(2):507-17. doi: 10.1016/s0091-3057(98)00006-9.
NMDA receptor antagonists have previously been reported to alter some pharmacological and behavioral effects of acute and chronic opioid administration. The present study assessed the interactions of NMDA antagonists with the discriminative stimulus properties of morphine. Adult male Long Evans rats were trained to discriminate 3.2 mg/kg of s.c. morphine from water under a two-lever fixed-ratio 10 schedule of food reinforcement. During test sessions. I.p. injections of the noncompetitive NMDA receptor antagonist dizocilpine (0.03-0.2 mg/kg), the competitive antagonists NPC 17742 (1-16 mg/kg), and SDZ 220-581 (0.1-3 mg/kg), the polyamine site antagonist eliprodil (3-17.3 mg/kg), the glycine-site partial agonist (+)-HA-966 (3-56 mg/kg), and the nonselective glutamate antagonist kynurenic acid (30-150 mg/kg) were coadministered with s.c. morphine (1-3.2 mg/kg; interaction tests) or water (generalization tests). In generalization tests, none of the compounds completely substituted for morphine. Concurrent administration of morphine and NMDA antagonists did not greatly alter the discriminative stimulus properties of morphine. Various doses of NPC 17742, SDZ 220-581, or (+)-HA-966 somewhat increased levels of morphine-appropriate lever selection, whereas some attenuation of morphine-lever selection was obtained when morphine was coadministered with eliprodil. These results show that NMDA antagonists have minimal interactions with the discriminative stimulus effects of morphine.
此前有报道称,N-甲基-D-天冬氨酸(NMDA)受体拮抗剂可改变急性和慢性阿片类药物给药的一些药理和行为效应。本研究评估了NMDA拮抗剂与吗啡辨别刺激特性之间的相互作用。成年雄性Long Evans大鼠在双杠杆固定比率10食物强化程序下接受训练,以区分皮下注射3.2mg/kg吗啡和水。在测试期间,腹腔注射非竞争性NMDA受体拮抗剂地佐环平(0.03 - 0.2mg/kg)、竞争性拮抗剂NPC 17742(1 - 16mg/kg)和SDZ 220 - 581(0.1 - 3mg/kg)、多胺位点拮抗剂依利罗地(3 - 17.3mg/kg)、甘氨酸位点部分激动剂(+)-HA - 966(3 - 56mg/kg)以及非选择性谷氨酸拮抗剂犬尿喹啉酸(30 - 150mg/kg),并与皮下注射的吗啡(1 - 3.2mg/kg;相互作用测试)或水(泛化测试)同时给药。在泛化测试中,没有一种化合物能完全替代吗啡。吗啡与NMDA拮抗剂同时给药并没有显著改变吗啡的辨别刺激特性。不同剂量的NPC 17742、SDZ 220 - 581或(+)-HA - 966在一定程度上增加了选择与吗啡相应杠杆的水平,而当吗啡与依利罗地同时给药时,吗啡杠杆选择出现了一定程度的减弱。这些结果表明,NMDA拮抗剂与吗啡的辨别刺激效应之间的相互作用最小。